Amrize Advises Against TRC Capital's Mini-Tender Offer

Amrize Ltd (NYSE: AMRZ) has recommended that its shareholders reject an unsolicited mini-tender offer from TRC Capital Investment Corporation. TRC aims to purchase 2,000,000 Amrize ordinary shares at $49.63 each, a price 4.48% lower than the market value of $51.96 per share as of August 26, 2025. This offer targets less than 1% of the company's outstanding shares and includes conditions such as a minimum closing price requirement, potentially placing shareholders at a disadvantage.

Amrize has urged its shareholders to seek updated market quotes, consult financial advisors, and approach TRC's offer with caution. Those who have already tendered shares can withdraw them before September 25, 2025. The SEC has previously warned that mini-tender offers might result in selling shares below market prices.